COPD-T2DM patients exhibit increased levels of oxidized low-density lipoproteins (ox-LDLs) and pro-inflammatory cytokines (TNF-α, IL-6, CRP), which trigger macrophage activation and foam cell formation, leading to plaque deposition in the arteries [73]. The gene discussed is IL6; the disease is type 2 diabetes mellitus.